APA

Yoo E. K., Cassin M., Lessin S. R. & Rook A. H. (20010823). Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. : Journal of the American Academy of Dermatology.

Chicago

Yoo E K, Cassin M, Lessin S R and Rook A H. 20010823. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. : Journal of the American Academy of Dermatology.

Harvard

Yoo E. K., Cassin M., Lessin S. R. and Rook A. H. (20010823). Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. : Journal of the American Academy of Dermatology.

MLA

Yoo E K, Cassin M, Lessin S R and Rook A H. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. : Journal of the American Academy of Dermatology. 20010823.